chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved. Not Provided          This case was linked to MOD-2021-079056 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up received on 05-MAY-2021 event outcome changed
I woke up about 4 a.m. cold but no fever body aches and pains I feel like my body is being crushed my joints hurt when I stand my head hurts I cannot get relief from Tylenol or Ibuprofen my face and neck are very puffy and I'm very tired
Joint pain that lasted for a few days but has resulted in the swelling in my right hand and inability to extend my fingers, clench my fist it close my fingers, and palm pain. This worsens at night. Extension of my fingers is the greatest concern, inability to hold objects or open doors.  This started the night of the vaccine, the same time when my injection site started to ache.  I felt pain in most joints, but the right hand got worse each day since the vaccine.
This spontaneous report as received from a pharmacist refers to a 69 year old male patient, who is also a physician. Patient's medical history, information about concomitant drugs or concurrent conditions were not provided. The patient had no drug reactions or allergies. On 23-SEP-2016, the patient was vaccinated with the first dose of PNEUMOVAX 23 (lot # L035687, expiry date: 16-FEB-2017), intramuscularly (arm, side not specified). On approximately 07-OCT-2016, (reported as: "approximately 14 days after the dose") the patient experienced tremors in the arm at the injection site in which a primary dose of PNEUMOVAX 23 was administered. The patient reported, that the tremor was "a little bothersome, but not to the point of limiting his function". He also stated, that the tremors were intermittent, not associated with activity or any particular time of the day and that tremor started in the muscle at the vaccination site and then radiated down the entire arm. No treatment was given and no lab diagnostics studies were performed. The patient did not recover from the event of tremor by the time of the report. The relatedness between the event and vaccination with PNEUMOVAX 23 was not reported. Additional information has been requested.
Information has been received from a certified medical assistant referring to multiple unspecified patients. On multiple unspecified dates the patients might have been vaccinated with PROQUAD (Merck) (lot # L002420, expiration date 23-JUL-2016), which were improperly stored at 4 centigrade for unspecified time frame. There was no previous temperature excursion. No adverse effect reported. This is one of the several reports received from the same reporter. Additional information has been requested.
pt recv vax;pain at inject site;axillary pain;HA & photophobia;rt arm  weakness;poor cognitive behavior;
Pediatric dose 0.2mL drawn up from adult Pfizer vial. 11-year-old patient received 0.2mL of the 12+ Pfizer vaccine. The mother of the patient notified at 6 pm on 12/2/2021 that her daughter got 0.2mL of adult Pfizer as discovered. Told her to monitor child for adverse effects.
LIGHTHEADEDNESS, NAUSEA W/ VOMITING X 1...FOR APPROX 5 HOURS...
This spontaneous report received from a nurse refers to a patient of unknown age. Information on pertinent medical history and concurrent condition was not provided. Information on pertinent medical history and concurrent condition was not provided. On an unknown date, the patient was vaccinated with VARIVAX lot # M038856 for prophylaxis. The Nurse reported that the vaccine administered was improperly stored. No adverse event reported. The outcome of incorrect product storage and no adverse event was unknown. Lot M038856 was stored in the range of -14°C to-10°C for 483 hours and in the range of -9°C to 8°C for 28 hours. No previous temperature excursion. The call was not because of a "data logger". Additional information has been requested.
Clinical history and exam consistent with acute urticaria, likely secondary to FluMist exposure. Absence of historical red flags or exam findings concerning for anaphylaxis or imminent threat to pulmonary capabilities. Will treat as outpatient with oral Benadryl and recommend avoidance of FluMist in the future. Warning signs/symptoms prompting reevaluation reviewed and pt vocalized understanding. Will f/u with PCM on PRN basis. Medication(s):   -UCC/MOD DIPHENHYDRAMINE 25MG CAP (12/BTL - TAKE 1 TO 2 CAPSULE BY MOUTH THREE TIMES A DAY AS NEEDED FOR ALLERGY SYMPTOMS #12 RF0
L shoulder vaccine site (deltoid) was reddened, warm + itchy on 4/25-4/26 worsened @ 48 hrs after inj.  Patient went to ED to have checked.  Now resolving on Keflex @ day 4.  On day 4 annular reddened, hand knot, 2"x2"
Left arm became painful throughout length; Became very lethargic; Trapezius muscle on left side spasmed; General body aches; chills; Fever (101.0 F); This is a spontaneous report from a contactable other healthcare professional, the patient. A 31-year-old non- pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727), via an unspecified route of administration in left arm on 27Mar2021 at 09:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar Type 2. The patient was received acetaminophen (MANUFACTURER UNKNOWN) for an unknown indication and other unspecified medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6205), via an unspecified route of administration in left arm on 06Mar2021 at 09:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to sulfa drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 13:00 (4 hours after vaccination), the patient experienced left arm became painful throughout length and became very lethargic, trapezius muscle on left side spasmed when attempts were made to get up from a nap by pushing off with left arm. Slowly developed general body aches, chills, fever (101.0 F) that was refractory to acetaminophen. No treatment was received for any events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of events pain in left arm, lethargy, general body pain, chills, fever (also reported as ongoing for last 14 hours) and muscle spasm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Large red, warm, swollen circle at injection site slightly larger than a tennis ball with some itchiness. Spoke with physician due to past cellulitis reactions to vaccines in left arm and discussed concerns due to knee replacement in April 2022. Treatment included antihistamines, cold compresses, and a short course (7days) of prophylactic antibiotic Doxycycline to mitigate infection concern. Symptoms as of 7/26/2022 have largely resolved with only slight pink area at injection site.
Patient stated she had a headache, stiff joints, abdominal pain, nausea and it was hard to move
3 x 4 cm erythema, mild firmness/warmth left thigh after PROQUAD injection. BENADRYL was given 2.5 ml (12.5 mg/5m).
The patient's son said his mother complained of dizziness, headache, confusion and very high blood pressure. He brought her to the emergency room where her blood pressure was found to be extremely high. The staff told him she was reacting to the Moderna Vaccine.
skin on her left hand is darker/My left hand is darker than my right hand; the skin color is darker; feeling tired; sore arm; headache; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 70-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 04Feb2021 (Batch/Lot Number: EL3302) as SINGLE DOSE for covid-19 immunisation. There was scheduled to receive the second vaccine on the 26Feb. The patients medical history and concomitant medications were not reported.  She received the first injection in her left arm and had noticed skin on her left hand is darker than my right hand, feeling tired, sore arm, headache  on an unspecified date. Her hand did not hurt of feel different, but the color was visibly darker. The patient underwent lab tests and procedures however the results were not reported as the patient could not visit the doctor due to bad weather.  Therapeutic measures was taken in response to the event. The patient put some lotion hoping the color might come back. The outcome of the events were unknown.  No follow-up attempts possible. No information expected.
14Apr sent to do lab for D Dimer which results received on Friday 16Apr indicated 1.23>.50; swelling and extreme tightness in both calves; swelling and extreme tightness in both calves; shortness of breath; muscle pain on top muscle area of both thighs; fatigue; This is a spontaneous report from a non-contactable consumer (patient). A 63-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration in left arm on 01Mar2021 at 17:00 (at the age of 63-year-old) as single dose for COVID-19 immunization at Hospital. Medical history of the patient included asthma, hypothyroid, high blood pressure, sinus, migraines. Patient had no known allergies. Concomitant/other medications in two weeks included Prescribed Medication (unspecified). Patient did not receive any other vaccine in four weeks. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. On 02Mar2021, patient experienced general fatigue and on 08Mar2021, patient experienced swelling and extreme tightness in both calves; muscle pain on top muscle area of both thighs, tightness and swelling was still there as of 20Apr2021, shortness of breath experienced for various situations where exerting more energy was required like walking up stair. Contacted PCP for visit in third week of Mar-appointment was set for mid Apr; pain continued. On 10Apr2021 visit, labs tests were done for salt-exercise, diet and stretching suggested; report received 13Apr2021 with negative results, 14Apr2021 patient was sent to do lab tests for D Dimer which results received on Friday 16Apr2021 indicated 01.23>.50; late response the day from PCP and went to ER for Ultrasound scan to check for blood clots. Report from ER indicated no blood clot found, suggested follow up with PCP-PT or other follow up from ER. On 19Apr2021 received response from PCP regarding follow up actions referring to PT services. General fatigue experienced for three weeks following vaccine (02Mar-27). AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment included physical therapy. Outcome of the events were resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
had a shaking episode on noc p/vax lasted <1min; body became loose; ?sz;
no adverse effects to the patient; 13 month old was given ZOSTAVAX on 12/04/2018; This spontaneous report was received from a nurse, referring to a 13 months old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies were not provided.  On 04-DEC-2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot # N026815, expiration date 25-DEC-2018; strength, dose, frequency, route) for prophylaxis (inappropriate schedule of product administration). Nurse reported that the office was doing an audit and discovered the error. Nurse reported no adverse effects to the patient.
pt was seen in the office on 10SEP98 for 4mo check up;recv vax died early evening on 10SEP98;15SEP98 MD reports poss SIDS:vaccine related pending;
Dizziness; This is a spontaneous report from a contactable female consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on 17Jul2021 as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient inquired about the timing of second dose if can it be a little longer than 3 weeks. She was reading on the internet and saw where her period could last 14 days instead of like 5 days. She read where women have been experiencing different/changes in menstrual cycles. On an unspecified date in Jul2021, the patient experienced some dizziness after the first vaccine dose. The patient inquired if any was available regarding menstrual changes and one dose help prevent the infection after getting one dose. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Arm Swollen 13x 12cm redness, swelling streaking around inner part of upper arm. Give Keflex 200 mg, Benadryl and RTC 11/15.
Severe lower and mid-back pain; tightness; Muscle spasms; This is a spontaneous report from a contactable nurse. A 32-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number 9231), intramuscular in left arm on 28Dec2020 13:30 at a single dose for COVID-19 immunization. Medical history included Migraines, hyperthyroidism, ankylosing spondylitis, and hypertension. Concomitant medication included lisinopril, methimazole, rizatriptan, topiramate, galcanezumab (EMGALITY, alprazolam,  ethinylestradiol, norgestimate (MONO LINYAH), diphenhydramine hydrochloride (BENADRYL), ubrogepant (UBRELVY) nd birth control. The vaccine was administered in a hospital. The patient was not diagnosed COVID-19 prior to vaccinations. The patient previously took macrobid [clarithromycin] and experienced rash. On 29Dec2020 04:30, the patient experienced severe lower and mid-back pain, tightness, and muscle spasms. Back pain persisted until early morning 30Dec2020. Rotated Tylenol and Ibuprofen, and used heat with minimal relief. The outcome of the event severe lower and mid-back pain was recovered on 30Dec2020 while the remaining events recovered on an unknown date. The patient was did not have covid-19 test post vaccination. The event was assessed as non-serious.
Approximately 10 minutes after administration the patient developed redness and itching around the site of the injection and a white welt.
Got the second dose of the Moderna Covid-19 vaccine and was 16 years old; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got the second dose of the Moderna Covid-19 vaccine and was 16 years old) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 058A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got the second dose of the Moderna Covid-19 vaccine and was 16 years old) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 23-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got the second dose of the Moderna Covid-19 vaccine and was 16 years old) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            No concomitant medications provided. No treatment medications provided.   This case was linked to MOD-2021-390030 (Patient Link).
Information has been received from a nurse practitioner concerning a female who on an unspecified date was vaccinated with a first dose of GARDASIL. Shortly after receiving the first dose of GARDASIL the patient experienced lightheadedness. Subsequently, the patient recovered from lightheadedness. The adverse event occurred at office. Additional information has been requested.
Arm is still a lil sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 27th August 2021, the patient received the 1st dose of Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows; This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient stated that got shingles vaccine yesterday and experienced little arm sore but no other reactions. The reporter did not consented to follow up as no patients details provided.
23Oct95 Pt recv 1 dose vax. Nov97 Pt devel varicella. Pt's brother also reported (98020204). 1 of the Pt's required tx w/acyclovir for mucous membrane & conjunctival involvement.
Left arm around injection site became inflamed and extremely itchy (about the size of a silver dollar the next day). The inflamed area measured 3 inches across and 3½ inches down. I took Benadryl and Tylenol. I applied some Ivarest for about 5 days. This is day 13. Area redness is very faint but still itchy. COVID-19 arm.
Redness, swelling and soreness around injection site. Started around 8 hours after shot. Fatigue started after a few hours. Achey and headache when woke up next day.
Well defined, limited red, raised rash periumbilical, (L) hip. No drainage, no pain, positive itch.
This spontaneous report as received from an other health professional refers to a patient of unknown age. On 28-DEC-2012 the patient was vaccinated with the first dose of RECOMBIVAX HB (dose, route and lot# not reported). On 26-MAR-2013 the patient was vaccinated with the second dose of RECOMBIVAX HB. On 30-MAY-2013 the patient was vaccinated with the third dose of RECOMBIVAX HB. No adverse event reported. Additional information is not expected.
24 hours, post vax, I started feeling hot and dizzy and my arm started feeling heavy. I went ER at approx. 22:00, Saturday night, the 16th. On Sunday morning, I felt worse. My arm was sore, I could barely move it. I looked in the mirror and the site of the TD had a red circle around it and from the site down to almost my elbow looked like cottage cheese and was red. It was red all the way down to almost my elbow. Small amount of soreness. Dx'd with cellulitis.
Day number 8 woke up with a red spot approx the size of a baseball, hot to touch
Within hours of vaccination (night of vaccination day) infant became febrile. At approximately 2:00AM on 1/26/2012, he was taken to hospital because of breathing difficulty. Infant was resuscitated at hospital but expired on 1/27/2012.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 15-DEC-2016, the patient was inadvertently vaccinated with a dose of ROTATEQ orally, which had a lot # L008053 and an expiration date of 30-NOV-2016 (concentration and dose were not provided), for prophylaxis. Additional information has been requested.
55 patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture). On 16-Dec-2021, EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Pt recv vax on unknown day; post vax pt exp vax site redness, swelling & warmth
Weakness left leg and hand; Shaking left hand; Computerised Tomogram Head Normal; Full blood count normal; Metabolic Function Test; This case was retrieved during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2453697-1. The original narrative from the sender is the following:  Mom report baby shaking left hand , weakness left leg and hand on 9/20/22 in am. Went to Er all test negative. Ct negative, labs negative. Sent home for monitoring.  The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events " Weakness left leg and hand", "shaking left hand."  Due to the nature of events the causal relationship between Vaxelis and "Computerised Tomogram Head Normal, Full blood count normal, Metabolic Function Test" was not applicable.  No further information is expected.
5/16 1230 Vaginal delivery 5/17 1349, 1350 received TDaP and Pneumovax 5/18 0050 fever 100.5 with shivering, sore throat 5/18 0745 whole body ache, site from pneumococcal vaccine reddened and size of quarter 1400 temp 101.8, site red and indurated 3cm x 2cm with pain 12 cm x 15 cm between shoulder and elbow, ice to site, CBC, UA ordered 2030 temp 102.3, blood cultures, chest xray ordered, started on clindamycin and Levaquin 5/19 feels weak, are sore, erythema 5 cm, dx cellulitis 5/20 10 cm erythema, fells better, dc home
PATIENT EXPERIENCING INTENSE PAIN ON HER LEFT SIDE FROM HER SHOULDER TO HER ARM. NO FEVER PER PATIENT.
Patient presented on 9/15/05 with c/o elevated temperature (101.8) x 2-3 days, nauea, malaise, and anorexia. He reported his general malaise began soon after receiving his small pox vaccination. Ordered to quarters, patient to push fluids/salts. Meclizine 25mg tid ordered.